Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 17 | 2022 | 2330 | 2.270 |
Why?
|
Carcinoma, Hepatocellular | 10 | 2024 | 2297 | 1.820 |
Why?
|
Living Donors | 6 | 2019 | 641 | 1.060 |
Why?
|
End Stage Liver Disease | 3 | 2022 | 352 | 0.970 |
Why?
|
Liver Neoplasms | 8 | 2024 | 4317 | 0.930 |
Why?
|
Hypertension, Renovascular | 2 | 2021 | 116 | 0.900 |
Why?
|
HSP40 Heat-Shock Proteins | 3 | 2024 | 83 | 0.890 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 2 | 2024 | 12 | 0.860 |
Why?
|
Aortic Diseases | 4 | 2020 | 735 | 0.850 |
Why?
|
Tissue Donors | 7 | 2022 | 2332 | 0.760 |
Why?
|
Aorta | 3 | 2020 | 2041 | 0.740 |
Why?
|
Arterial Occlusive Diseases | 3 | 2020 | 748 | 0.730 |
Why?
|
Renal Artery Obstruction | 1 | 2020 | 219 | 0.660 |
Why?
|
Hepatic Artery | 1 | 2019 | 232 | 0.620 |
Why?
|
Donor Selection | 2 | 2019 | 232 | 0.610 |
Why?
|
Neoplasms, Muscle Tissue | 2 | 2017 | 67 | 0.570 |
Why?
|
Organoids | 1 | 2022 | 746 | 0.530 |
Why?
|
Tissue Expansion Devices | 4 | 2020 | 156 | 0.520 |
Why?
|
Graft Survival | 10 | 2020 | 3820 | 0.490 |
Why?
|
Proto-Oncogene Proteins | 2 | 2019 | 4514 | 0.470 |
Why?
|
Vascular Surgical Procedures | 2 | 2020 | 1489 | 0.450 |
Why?
|
Aorta, Abdominal | 5 | 2018 | 625 | 0.450 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1609 | 0.440 |
Why?
|
Viscera | 1 | 2014 | 138 | 0.440 |
Why?
|
Up-Regulation | 1 | 2022 | 4125 | 0.420 |
Why?
|
Hepatocyte Growth Factor | 1 | 2014 | 271 | 0.410 |
Why?
|
Liver Regeneration | 1 | 2014 | 213 | 0.410 |
Why?
|
Mesentery | 1 | 2013 | 202 | 0.400 |
Why?
|
Esophagus | 2 | 2016 | 1033 | 0.380 |
Why?
|
Tissue Expansion | 3 | 2020 | 160 | 0.380 |
Why?
|
Epithelial Cells | 1 | 2022 | 3677 | 0.360 |
Why?
|
Liver | 5 | 2020 | 7528 | 0.350 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2014 | 333 | 0.350 |
Why?
|
Kidney Transplantation | 5 | 2019 | 4235 | 0.350 |
Why?
|
Abdominal Injuries | 1 | 2013 | 360 | 0.340 |
Why?
|
Intraoperative Care | 1 | 2013 | 767 | 0.330 |
Why?
|
Hospitals, Pediatric | 3 | 2020 | 1860 | 0.330 |
Why?
|
Mesenteric Arteries | 2 | 2020 | 178 | 0.320 |
Why?
|
Body Weight | 1 | 2019 | 4618 | 0.320 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1136 | 0.320 |
Why?
|
Phosphoproteins | 2 | 2018 | 2448 | 0.310 |
Why?
|
Aortic Valve Stenosis | 3 | 2018 | 2001 | 0.300 |
Why?
|
Organ Transplantation | 3 | 2017 | 1157 | 0.300 |
Why?
|
Biliary Tract | 1 | 2008 | 135 | 0.300 |
Why?
|
Thrombosis | 2 | 2019 | 2942 | 0.290 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2018 | 2898 | 0.280 |
Why?
|
Wounds, Nonpenetrating | 1 | 2013 | 807 | 0.270 |
Why?
|
Postoperative Complications | 6 | 2019 | 15633 | 0.270 |
Why?
|
Child | 22 | 2024 | 80158 | 0.260 |
Why?
|
Renal Artery | 2 | 2020 | 351 | 0.260 |
Why?
|
Child, Preschool | 18 | 2020 | 42232 | 0.250 |
Why?
|
Infant | 17 | 2020 | 36193 | 0.250 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 1496 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2022 | 8554 | 0.240 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5799 | 0.230 |
Why?
|
Decision Support Techniques | 1 | 2013 | 1998 | 0.210 |
Why?
|
Cell Proliferation | 3 | 2016 | 10451 | 0.210 |
Why?
|
Syndrome | 5 | 2020 | 3267 | 0.200 |
Why?
|
Nephrectomy | 3 | 2019 | 937 | 0.200 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2024 | 1469 | 0.200 |
Why?
|
Kidney | 4 | 2021 | 7048 | 0.190 |
Why?
|
Alagille Syndrome | 1 | 2021 | 45 | 0.190 |
Why?
|
Pancreas Transplantation | 1 | 2022 | 197 | 0.190 |
Why?
|
Adolescent | 19 | 2024 | 88326 | 0.170 |
Why?
|
Humans | 49 | 2024 | 761596 | 0.170 |
Why?
|
Infant, Newborn | 7 | 2017 | 26202 | 0.170 |
Why?
|
Replantation | 1 | 2020 | 145 | 0.170 |
Why?
|
Treatment Outcome | 16 | 2024 | 64685 | 0.160 |
Why?
|
Iliac Artery | 1 | 2020 | 343 | 0.160 |
Why?
|
Immunophenotyping | 1 | 2024 | 1869 | 0.160 |
Why?
|
Biliary Atresia | 1 | 2019 | 88 | 0.160 |
Why?
|
Transplantation, Autologous | 2 | 2020 | 2115 | 0.150 |
Why?
|
Mitochondria | 2 | 2022 | 3624 | 0.150 |
Why?
|
Male | 32 | 2024 | 360846 | 0.150 |
Why?
|
Signal Transduction | 3 | 2018 | 23447 | 0.150 |
Why?
|
Hyperoxaluria, Primary | 1 | 2017 | 24 | 0.150 |
Why?
|
Oxalates | 1 | 2017 | 98 | 0.140 |
Why?
|
Kidney Failure, Chronic | 3 | 2019 | 2472 | 0.140 |
Why?
|
Herpesvirus 8, Human | 1 | 2019 | 255 | 0.140 |
Why?
|
Constriction, Pathologic | 3 | 2021 | 1096 | 0.140 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2016 | 37 | 0.140 |
Why?
|
Choledochostomy | 1 | 2016 | 16 | 0.140 |
Why?
|
Hepatoblastoma | 1 | 2017 | 90 | 0.130 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.130 |
Why?
|
Connective Tissue Growth Factor | 1 | 2016 | 92 | 0.130 |
Why?
|
Umbilical Veins | 1 | 2017 | 426 | 0.130 |
Why?
|
Cyclin E | 1 | 2016 | 156 | 0.130 |
Why?
|
Sarcoma, Kaposi | 1 | 2019 | 374 | 0.130 |
Why?
|
Inflammation | 3 | 2020 | 10774 | 0.130 |
Why?
|
Blood Vessel Prosthesis | 1 | 2020 | 951 | 0.130 |
Why?
|
Abdominal Neoplasms | 1 | 2017 | 287 | 0.130 |
Why?
|
Female | 28 | 2024 | 392705 | 0.120 |
Why?
|
Time Factors | 6 | 2020 | 39969 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 1 | 2020 | 392 | 0.120 |
Why?
|
Retrospective Studies | 12 | 2020 | 80647 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2024 | 1088 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 629 | 0.120 |
Why?
|
Models, Animal | 3 | 2016 | 2112 | 0.110 |
Why?
|
Neurofibromatoses | 1 | 2018 | 299 | 0.110 |
Why?
|
Anastomosis, Surgical | 2 | 2018 | 983 | 0.110 |
Why?
|
Biotransformation | 1 | 2013 | 166 | 0.110 |
Why?
|
Liver Circulation | 1 | 2013 | 159 | 0.110 |
Why?
|
Organ Size | 2 | 2019 | 2254 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2017 | 415 | 0.110 |
Why?
|
Catheterization, Peripheral | 1 | 2017 | 343 | 0.110 |
Why?
|
Learning Curve | 1 | 2015 | 230 | 0.110 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2017 | 326 | 0.110 |
Why?
|
Acid-Base Equilibrium | 1 | 2013 | 181 | 0.110 |
Why?
|
Renal Veins | 1 | 2013 | 102 | 0.100 |
Why?
|
Mesenteric Artery, Superior | 1 | 2013 | 96 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2022 | 4281 | 0.100 |
Why?
|
Water-Electrolyte Balance | 1 | 2013 | 325 | 0.100 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1157 | 0.100 |
Why?
|
Age Factors | 3 | 2020 | 18399 | 0.100 |
Why?
|
Oncogene Proteins | 1 | 2016 | 719 | 0.100 |
Why?
|
Organogenesis | 1 | 2013 | 215 | 0.100 |
Why?
|
Heart Arrest | 1 | 2022 | 1514 | 0.100 |
Why?
|
Length of Stay | 2 | 2016 | 6426 | 0.100 |
Why?
|
Endovascular Procedures | 2 | 2018 | 2183 | 0.100 |
Why?
|
Hypertension | 4 | 2018 | 8540 | 0.100 |
Why?
|
Transplantation, Homologous | 3 | 2020 | 4807 | 0.090 |
Why?
|
Huntington Disease | 1 | 2018 | 1144 | 0.090 |
Why?
|
Boston | 4 | 2020 | 9327 | 0.090 |
Why?
|
Phosphorylation | 3 | 2021 | 8321 | 0.090 |
Why?
|
Neural Stem Cells | 1 | 2018 | 888 | 0.090 |
Why?
|
tau Proteins | 1 | 2021 | 2095 | 0.090 |
Why?
|
Hepatectomy | 1 | 2014 | 557 | 0.090 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2020 | 1428 | 0.090 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12059 | 0.090 |
Why?
|
Duodenum | 1 | 2014 | 490 | 0.090 |
Why?
|
Aortic Coarctation | 1 | 2012 | 275 | 0.090 |
Why?
|
Oxidative Stress | 1 | 2021 | 3113 | 0.090 |
Why?
|
Angioplasty | 1 | 2013 | 355 | 0.090 |
Why?
|
Portal Vein | 1 | 2013 | 431 | 0.090 |
Why?
|
Vena Cava, Inferior | 1 | 2013 | 458 | 0.080 |
Why?
|
Risk Factors | 6 | 2019 | 74213 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9420 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1036 | 0.080 |
Why?
|
Stomach | 1 | 2014 | 696 | 0.080 |
Why?
|
Hepatocytes | 1 | 2016 | 1233 | 0.080 |
Why?
|
Renin-Angiotensin System | 1 | 2013 | 737 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2917 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4652 | 0.080 |
Why?
|
Enzyme Activation | 1 | 2014 | 3597 | 0.080 |
Why?
|
Proteomics | 1 | 2022 | 3848 | 0.080 |
Why?
|
Biliary Tract Diseases | 1 | 2008 | 159 | 0.070 |
Why?
|
Creatinine | 1 | 2013 | 1899 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3449 | 0.070 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2015 | 1017 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13255 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6484 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2016 | 2910 | 0.070 |
Why?
|
Hippocampus | 1 | 2000 | 3766 | 0.070 |
Why?
|
Depressive Disorder | 1 | 2000 | 3728 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2013 | 809 | 0.070 |
Why?
|
Infant, Premature | 1 | 2017 | 2107 | 0.070 |
Why?
|
Pediatrics | 2 | 2020 | 3589 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3816 | 0.070 |
Why?
|
Models, Biological | 1 | 2022 | 9469 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4244 | 0.060 |
Why?
|
Blood Pressure | 1 | 2020 | 8481 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2178 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2018 | 12794 | 0.060 |
Why?
|
Liver Diseases | 1 | 2013 | 1297 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2242 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7593 | 0.060 |
Why?
|
Rats | 3 | 2016 | 23741 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3179 | 0.060 |
Why?
|
Databases, Factual | 2 | 2016 | 7968 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2013 | 2024 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2630 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3242 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39106 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2016 | 3744 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2015 | 3549 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3271 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9463 | 0.050 |
Why?
|
Gene Fusion | 1 | 2024 | 356 | 0.050 |
Why?
|
Transcription Factors | 2 | 2018 | 12130 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4793 | 0.040 |
Why?
|
Choline | 1 | 2000 | 515 | 0.040 |
Why?
|
Motor Neurons | 1 | 2024 | 870 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1055 | 0.040 |
Why?
|
Ganciclovir | 1 | 2019 | 252 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 250 | 0.040 |
Why?
|
Prognosis | 2 | 2019 | 29629 | 0.040 |
Why?
|
Waiting Lists | 1 | 2022 | 765 | 0.040 |
Why?
|
14-3-3 Proteins | 1 | 2018 | 220 | 0.040 |
Why?
|
Recurrence | 1 | 2009 | 8466 | 0.040 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2000 | 489 | 0.040 |
Why?
|
Collateral Circulation | 1 | 2018 | 294 | 0.030 |
Why?
|
Portal Pressure | 1 | 2017 | 60 | 0.030 |
Why?
|
Pressure | 1 | 2020 | 1154 | 0.030 |
Why?
|
Albumins | 1 | 2019 | 575 | 0.030 |
Why?
|
Fluoxetine | 1 | 2000 | 733 | 0.030 |
Why?
|
Young Adult | 6 | 2024 | 59260 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11904 | 0.030 |
Why?
|
Aortography | 1 | 2018 | 421 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 654 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2017 | 382 | 0.030 |
Why?
|
Thrombelastography | 1 | 2017 | 187 | 0.030 |
Why?
|
Animals | 6 | 2022 | 168475 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2009 | 11120 | 0.030 |
Why?
|
Biopsy | 2 | 2020 | 6766 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1496 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 462 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2016 | 8181 | 0.030 |
Why?
|
Platelet Count | 1 | 2017 | 781 | 0.030 |
Why?
|
Tissue and Organ Procurement | 2 | 2013 | 962 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2019 | 570 | 0.030 |
Why?
|
Adult | 7 | 2019 | 221210 | 0.030 |
Why?
|
Drug Resistance | 1 | 2000 | 1596 | 0.030 |
Why?
|
Frontal Lobe | 1 | 2000 | 1420 | 0.030 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2017 | 407 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1626 | 0.030 |
Why?
|
Risk Assessment | 2 | 2019 | 23996 | 0.030 |
Why?
|
Functional Laterality | 1 | 2000 | 2257 | 0.030 |
Why?
|
Ureterostomy | 1 | 2013 | 18 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2000 | 6019 | 0.030 |
Why?
|
Immunosuppressive Agents | 2 | 2019 | 4176 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 638 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2049 | 0.030 |
Why?
|
Aged | 3 | 2021 | 169310 | 0.030 |
Why?
|
Middle Aged | 4 | 2021 | 220921 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2003 | 2645 | 0.030 |
Why?
|
Hyperplasia | 1 | 2016 | 1152 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3578 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2009 | 11530 | 0.020 |
Why?
|
Synapses | 1 | 2021 | 1769 | 0.020 |
Why?
|
Paclitaxel | 1 | 2019 | 1732 | 0.020 |
Why?
|
Brain | 1 | 2018 | 27121 | 0.020 |
Why?
|
Hemoglobins | 1 | 2017 | 1526 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2018 | 2115 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2000 | 3769 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2017 | 1301 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4542 | 0.020 |
Why?
|
Liver Failure | 1 | 2012 | 250 | 0.020 |
Why?
|
Cohort Studies | 3 | 2019 | 41495 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1935 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2000 | 2639 | 0.020 |
Why?
|
Cadaver | 1 | 2013 | 1358 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3597 | 0.020 |
Why?
|
Brain Death | 1 | 2012 | 357 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12463 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2735 | 0.020 |
Why?
|
Macrophages | 1 | 2003 | 5767 | 0.020 |
Why?
|
Gestational Age | 1 | 2017 | 3577 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 2012 | 504 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 30053 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10090 | 0.020 |
Why?
|
Intestine, Small | 1 | 2012 | 1206 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9353 | 0.020 |
Why?
|
Radiography | 1 | 2017 | 6965 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3537 | 0.020 |
Why?
|
Graft Rejection | 1 | 2019 | 4446 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 16990 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15843 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 36426 | 0.010 |
Why?
|
United States | 3 | 2018 | 72340 | 0.010 |
Why?
|
Vasa Vasorum | 1 | 2003 | 25 | 0.010 |
Why?
|
Angiostatins | 1 | 2003 | 64 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2000 | 9001 | 0.010 |
Why?
|
Plasminogen | 1 | 2003 | 144 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13510 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 748 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8527 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9610 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9647 | 0.010 |
Why?
|
Depression | 1 | 2000 | 8126 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15266 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 673 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2003 | 605 | 0.010 |
Why?
|
Receptors, LDL | 1 | 2003 | 488 | 0.010 |
Why?
|
Lymphokines | 1 | 2003 | 927 | 0.010 |
Why?
|
Inositol | 1 | 2000 | 215 | 0.010 |
Why?
|
Feedback | 1 | 2003 | 791 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18255 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21355 | 0.010 |
Why?
|
Creatine | 1 | 2000 | 427 | 0.010 |
Why?
|
Mice | 2 | 2022 | 81539 | 0.010 |
Why?
|
Aspartic Acid | 1 | 2000 | 576 | 0.010 |
Why?
|
Cytosol | 1 | 2000 | 888 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 2003 | 1443 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17904 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58984 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1651 | 0.010 |
Why?
|
Monocytes | 1 | 2003 | 2570 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54423 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2003 | 3492 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6345 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2003 | 5112 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20568 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2003 | 14417 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2003 | 22174 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2000 | 22176 | 0.000 |
Why?
|